Skip to main content

Day: April 9, 2020

MAGNETIC NORTH ACQUISITION CORP. ANNOUNCES AGREEMENT FOR THE SALE OF PREVICARE’S DISINFECTANT PRODUCT TO US GOVERNMENTS

**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United States.  Any failure to comply with this restriction may constitute a violation of U.S. Securities Laws**CALGARY, Alberta and TORONTO, April 09, 2020 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC) (“Magnetic North” or the “Company”) is pleased to announce that one of its investee companies, Previcare, Inc. (“Previcare”) has entered into an agreement (the “Agreement”) with a Homeland Security consulting firm to assist and provide guidance in connection with the sale of products related to the COVID-19 pandemic, to certain US Federal and State government agencies and organizations.  As an initial action under the Agreement, Previcare is working on a purchase order to...

Continue reading

COREPOINT LODGING PROVIDES UPDATE ON OPERATIONS AND MEASURES TO MITIGATE IMPACT OF COVID-19

IRVING, Texas, April 09, 2020 (GLOBE NEWSWIRE) — CorePoint Lodging Inc. (NYSE: CPLG) (“CorePoint” or the “Company”), a pure play select-service hotel owner strategically focused on the midscale and upper-midscale segments, provided an update today on its operations and the aggressive cost containment measures to mitigate the ongoing operational and financial impact from the COVID-19 virus as well as an update on asset sales.“We continue to work with our third-party manager to place the health and safety of our hotels’ guests and employees above all else in this period of unprecedented disruption and uncertainty for the lodging industry,” noted Keith Cline, President and Chief Executive Officer of CorePoint. “In mid-March, we began taking aggressive steps at the corporate and hotel level to control costs and preserve capital.  As...

Continue reading

Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development

Pfizer and BioNTech to jointly develop COVID-19 vaccine, initially in the United States and Europe, and scale-up manufacturing capacity to support global supplyPotential to supply millions of vaccine doses by the end of 2020 subject to technical success of the development program and approval by regulatory authorities, and then rapidly scale up capacity to produce hundreds of millions of doses in 2021 

Continue reading

BioNTech und Pfizer geben weitere Details zur Kollaboration bekannt, um globale COVID-19-Impfstoffentwicklung voranzutreiben

Pfizer und BioNTech entwickeln gemeinsam einen Impfstoff gegen COVID-19, zunächst in den USA und Europa, und erhöhen die Produktionskapazitäten zur Unterstützung der globalen VersorgungPotenzial zur Herstellung von Millionen an Impfstoffdosen bis Ende 2020, vorbehaltlich des technischen Erfolgs des Entwicklungsprogramms und der Genehmigung durch die Behörden, sowie rascher Ausbau der Kapazität zur Herstellung von Hunderten von Millionen Dosen im Jahr 2021

Continue reading

Delta Drone – The transport of packages by drone, future strategic tool for major health crises

The transport of packages by drone,future strategic tool for major health crisesDardilly and Tel Aviv, 8 April 2020The drone package transport projectAs part of a future project for enabling drones based services operation in urban envirionment such as delivery of parcels, the city of Tel Aviv (Israel) via its innovation implementation hub (CityZone), retained the company ParaZero to carry out, from 2020, the first experiments and proof of concept of an adapted system, ensuring the highest level of safety and reliability. These experiments will be carried out in real situations through the use of an entire district of the city.About this very innovative project, Mrs. Liora Schechter, CIO of the Municipality of Tel Aviv said:« As part of our vision of shaping better cities for tomorrow, we see the involvment of drones as a pilar element...

Continue reading

NexTech Reports Record Breaking Revenue and Gross Profit for March

NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the industry leader in augmented reality, is pleased to announce that it has achieved record revenue and gross profit for the month of March 2020. Both revenue and gross profit surged in March and is continuing to surge in April. Notably, the company achieved $1,000,000 in booked revenue last month and the highest revenue ever achieved in a single month, which represents a 270% increase in revenue year over year.Evan Gappelberg, CEO of NexTech comments, “We had over $3million in cash and inventory on hand at the end of March which means the company is perfectly poised to ride out the COVID19 new economy”. He continues, “As a diversified company we have multiple business segments that are benefiting...

Continue reading

MATRIX SERVICE COMPANY PROVIDES OPERATIONS UPDATE AND BUSINESS RESPONSE TO COVID-19 PANDEMIC

TULSA, Okla., April 09, 2020 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX) (“Matrix” or “the Company”), a leading contractor to energy and power markets across North America, today provided an update regarding the Company’s operations and the impacts of the COVID-19 pandemic and the reduction in crude oil demand.“Our first priority during this unprecedented event is the health and safety of our employees,” said Matrix Service Company President and CEO John R. Hewitt. “We are proud of how our employees have stepped up to the challenge and remained focused on our business priorities while doing their part to limit the spread of COVID-19. While there is uncertainty around the duration of the impact of the pandemic, we all share the responsibility of following the recommended CDC precautions to help shorten the timeline....

Continue reading

New FTI Consulting Survey Finds Americans Are Paying Attention to Major Corporates Amid Pandemic, Looking for Leaders

WASHINGTON, April 09, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the results of a new U.S. national survey, titled Shifting Expectation, that finds Americans are attuned to how companies are behaving during the global COVID-19 pandemic.The Strategic Communications segment at FTI Consulting conducted a survey among a nationally representative sample of American adults between March 25-30. The survey was designed to understand a range of attitudes and behaviors related to personal finances, economic expectations, and the response from businesses and governments across the country.Most notably, the report found Americans are closely watching how companies are managing and responding to COVID-19 implications:83% are paying more attention than usual to “leaders/CEOs stepping up to help those in need,” (46%...

Continue reading

Liquidia to Present at the 19th Annual Needham Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., April 09, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT® technology, today announced that Neal Fowler, Chief Executive Officer of Liquidia, will present a company overview virtually at the 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 9:20am Eastern time.A link to the live audio webcast and replay of the presentation will be available on the Events & Presentations page of the Company’s corporate website, and will be archived for a minimum of 90 days.About LiquidiaLiquidia is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary...

Continue reading

Otonomy Provides Business Update Related to COVID-19 Pandemic

SAN DIEGO, April 09, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today provided a business update related to the COVID-19 pandemic.“Our first priority during this international crisis has been to ensure the health and safety of our employees, patients enrolled in our clinical trials, and healthcare professionals at our study sites in the United States and Europe,” said David A. Weber, Ph.D., president and CEO of Otonomy. “We are fortunate that the primary endpoint for our OTIVIDEX® Phase 3 trial and key exploratory endpoints in our OTO-313 Phase 2 trial are self-reported by the patient from home thereby preserving the integrity of data collection in these trials even in locations with quarantine restrictions. However, new...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.